Literature DB >> 2783355

Two- to eight-year survival rates in patients who refused coronary artery bypass grafting.

W Hueb1, G Bellotti, J A Ramires, P Lemos da Luz, F Pileggi.   

Abstract

One hundred and fifty patients with coronary artery disease (CAD) who refused bypass grafting were followed prospectively from 2 to 8 years. Mean age was 57 +/- 8 (standard deviation) years. Ejection fraction averaged 70 +/- 14%. Eight percent of patients had 1-vessel CAD and 92% had multiple-vessel CAD. Medical treatment included propranolol, nifedipine, isosorbide dinitrate, dipyridamole and aspirin. Annual mortality was 0% for 1- and 2-vessel CAD and 1.3% for left main equivalent disease, 3-vessel and left main CAD. Treatment significantly reduced the incidence of stable and unstable angina. Fifty-two patients (34%) had a second hemodynamic study 4.2 +/- 1.3 years after initial evaluation. Stenosis progression or new significant obstructions (greater than or equal to 70%) in previously normal coronary arteries occurred in 61% of 123 arteries studied, whereas new occlusions were observed in 12% of the arteries. Nonfatal acute myocardial infarction incidence was 8%. No significant changes occurred in ejection fraction. In conclusion, proper medical treatment in selected patients with advanced CAD but preserved ventricular function is associated with good long-term survival and remission of symptoms, although progression of coronary atherosclerosis does occur in some patients.

Entities:  

Mesh:

Year:  1989        PMID: 2783355     DOI: 10.1016/0002-9149(89)90277-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  3 in total

1.  Coronary bypass graft surgery: reexamining the assumptions.

Authors:  H S Friedman
Journal:  J Gen Intern Med       Date:  1990 Jan-Feb       Impact factor: 5.128

2.  The Ottawa Heart Institute: it's good, but can we afford it?

Authors:  P P Morgan; L Cohen
Journal:  CMAJ       Date:  1990-03-15       Impact factor: 8.262

Review 3.  Conservative strategy for treatment of stable coronary artery disease.

Authors:  Paulo Cury Rezende; Thiago Luis Scudeler; Leandro Menezes Alves da Costa; Whady Hueb
Journal:  World J Clin Cases       Date:  2015-02-16       Impact factor: 1.337

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.